Please login to the form below

Not currently logged in
Email:
Password:

AB-506

This page shows the latest AB-506 news and features for those working in and with pharma, biotech and healthcare.

Arbutus hit hard as new hep B drug fails on safety

Arbutus hit hard as new hep B drug fails on safety

A combination study of AB-506 and AB-729 was due to start next year but now won’t go ahead. ... Arbutus’ other candidates in development for HBV include follow-on oral capsid inhibitors that have different chemical structures, so may avoid the

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...